ATEC Q2 revenue $214M (+15% YoY); raises FY2026 adjusted EBITDA guidance to $140M

Alphatec Holdings, Inc.

Total revenue $214M (+15% YoY); surgical revenue $196M (+17% YoY) on 20% case volume growth.
GAAP net loss $26M; Non-GAAP net income $11M; adjusted EBITDA $36M (16.8% margin, +420 bps YoY).
Net new surgeon users +24%; ending cash $119M; positive free cash flow.
FY2026 revenue reaffirmed at ~$882M; adjusted EBITDA guidance raised to ~$140M (from ~$134M).
Expects at least $20M free cash flow for FY2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.